Loading...
skip to Main Content

Register for #ILC2021 with early fees & enjoy savings of up to EUR 450!

So how about upgrading your bike? 🚵‍♂️🚴‍♂️🚴 Too much time inside calls for some outdoor exercise.

➡️Register now: https://easl.eu/ILC2021-reg

Tell us below what you’ll do with your early-fee savings.

CHB patients routinely undergo screening for #HCC, but the efficacy of screening is unclear.

@gnioannou, @FengSu_MD & co. reported that screening by ultrasound and/or serum AFP was associated with a reduction in HCC-related mortality.

Read: https://bit.ly/3nZsMjR
#LiverTwitter

Webcast description

In the rapidly developing field of COVID-19 virology, Professor Darius Moradpour hosts this update to our current understanding of SARS-CoV-2 infection, supported by three world-renowned experts looking at the major challenges that lie ahead.

Although multiple vaccines have now been approved, one of the most important ongoing complications of the SARS-CoV-2 pandemic will be to monitor and adapt to the emergence of new variants. In this webcast, the experts explore current understanding of coronavirus evolution, which can lead to antigenic drift and the potential for immune escape, and discuss the possible implications for transmission and human health.

Looking at the clinical characteristics of SARS-CoV-2 infection, the experts also discuss ongoing progress in the use of antiviral therapy, the evidence around SARS-CoV-2 infection in hepatocytes and liver injury, and special considerations in immunosuppressed patients.

Moderator: Darius Moradpour
Panel:
  • Sandra Ciesek
  • Jan Felix Drexler
  • Volker Thiel

Learning objectives

  • Understand the evolution of coronaviruses, including antigenic drift and the potential for immune escape
  • Learn about the possible implications for transmission and human health
  • Understand the clinical characteristics of SARS-CoV-2 infection
  • Learn about the currently used antiviral therapy
  • Learn about SARS-CoV-2 infection in hepatocytes and the consequences on liver injury

Target audience

  • General practitioners
  • Hepatologists
  • Health care professionals
  • Clinical researchers and scientists

Register for #ILC2021 with early fees & enjoy savings of up to EUR 450!

So how about upgrading your bike? 🚵‍♂️🚴‍♂️🚴 Too much time inside calls for some outdoor exercise.

➡️Register now: https://easl.eu/ILC2021-reg

Tell us below what you’ll do with your early-fee savings.

CHB patients routinely undergo screening for #HCC, but the efficacy of screening is unclear.

@gnioannou, @FengSu_MD & co. reported that screening by ultrasound and/or serum AFP was associated with a reduction in HCC-related mortality.

Read: https://bit.ly/3nZsMjR
#LiverTwitter

Back To Top